NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer

Title
NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages theoncologist.2018-0292
Publisher
Alphamed Press
Online
2018-08-03
DOI
10.1634/theoncologist.2018-0292

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More